Amanote Research

Amanote Research

    RegisterSign In

Frovatriptan as Preemptive Treatment for Fasting-Induced Migraine

Headache - United Kingdom
doi 10.1111/j.1526-4610.2010.01827.x
Full Text
Open PDF
Abstract

Available in full text

Categories
Neurology
Date

January 26, 2011

Authors
Meryl LatskoStephen SilbersteinNoah Rosen
Publisher

Wiley


Related search

Review of Frovatriptan in the Treatment of Migraine

Neuropsychiatric Disease and Treatment
PsychiatryMental HealthBiological Psychiatry
2008English

A Double-Blind, Randomized, Multicenter, Italian Study of Frovatriptan Versus Almotriptan for the Acute Treatment of Migraine

Journal of Headache and Pain
MedicineNeurologyAnesthesiologyPain Medicine
2011English

Frovatriptan vs. Transdermal Oestrogens or Naproxen Sodium for the Prophylaxis of Menstrual Migraine

Journal of Headache and Pain
MedicineNeurologyAnesthesiologyPain Medicine
2007English

Frovatriptan vs Other Triptans in the Treatment of Menstrual Migraine: Pooled Analysis of Three Double-Blind, Randomized, Cross-Over Studies

Journal of Headache and Pain
MedicineNeurologyAnesthesiologyPain Medicine
2013English

Treatment Options for Vestibular Migraine

US Neurology
NeuroscienceNeurology
2016English

Efficacy of Feverfew as Prophylactic Treatment of Migraine

BMJ
1985English

Efficacy of Feverfew as Prophylactic Treatment of Migraine.

BMJ
1985English

Acute Migraine Treatment - Information for Patients

Canadian Journal of Neurological Sciences
MedicineNeurology
2013English

Fremanezumab for Preventive Treatment of Migraine

Neurology
Neurology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy